561
Participants
Start Date
October 30, 2022
Primary Completion Date
September 30, 2023
Study Completion Date
September 30, 2023
Tegoprazan
tegoprazan-containing bismuth quadruple therapy or Esomeprazole-containing bismuth quadruple therapy; Route of administration: oral;
Peking University Third Hospital, Beijing
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
INDUSTRY